5.3 Respiratory & Immune System Pathology

Respiratory & Immune System Pathology

Clinical Core: Treating respiratory and autoimmune pathologies requires an understanding of thoracic compliance and joint stability. For example, patients with advanced COPD rely on accessory neck muscles to survive, meaning overly aggressive myofascial stripping can induce respiratory panic; similarly, rheumatoid synovial pannus can quietly erode the transverse ligament of the atlas, turning routine cervical mobilization into a catastrophic spinal cord injury.

---

1. Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD) is a progressive, largely irreversible respiratory disorder characterized by persistent airflow limitation resulting from chronic airway inflammation and parenchymal tissue destruction. The primary etiological driver is long-term exposure to noxious gases and particulate matter, predominantly tobacco smoke and occupational biomass fuels. COPD encompasses two classic clinical phenotypes that frequently coexist in individual patients:

The Two Classical COPD Phenotypes

                              [COPD Spectrum]
                               /            \
                              /              \
           [Chronic Bronchitis]              [Emphysema]
          - "Blue Bloater"                  - "Pink Puffer"
          - Bronchial inflammation          - Alveolar wall destruction
          - Mucus hypersecretion            - Loss of elastic recoil
          - Hypoxemia & Cor Pulmonale       - Barrel chest & Pursed-lip breathing

1. Chronic Bronchitis ("The Blue Bloater")

• Clinical Diagnostic Definition: Persistent productive cough producing sputum for at least 3 consecutive months in 2 successive years, with other pulmonary or cardiac causes excluded.
• Pathophysiology: Chronic irritants trigger profound hypertrophy of submucosal bronchial mucus glands and goblet cell hyperplasia, leading to copious, tenacious mucus hypersecretion. The mucociliary escalator is paralyzed, precipitating chronic bacterial colonization, chronic airway inflammation, and peribronchiolar fibrosis that narrows small airways.
• Physiological Consequences: Marked ventilation-perfusion mismatch leads to chronic hypoxemia and hypercapnia. Secondary erythrocytosis (polycythemia) increases blood viscosity. Chronic hypoxic vasoconstriction of pulmonary arterioles induces pulmonary arterial hypertension, culminating in right ventricular hypertrophy and failure (cor pulmonale), manifested clinically as jugular venous distension, hepatomegaly, and severe dependent peripheral edema.
• Clinical Appearance: Often stocky or cyanotic ("blue") with an audible, productive morning cough and peripheral edema.

2. Pulmonary Emphysema ("The Pink Puffer")

• Pathological Definition: Permanent, abnormal enlargement of airspaces distal to the terminal bronchioles, accompanied by destructive breakdown of alveolar septal walls without significant fibrosis.
• Pathophysiology: Chronic inflammatory cells (alveolar macrophages, CD8+ T-lymphocytes, neutrophils) release excessive proteolytic enzymes, particularly elastase. Concurrently, tobacco smoke inactivates endogenous alpha-1 antitrypsin (a crucial antiprotease). This protease-antiprotease imbalance digests elastin in the alveolar walls and pulmonary capillary bed.
• Physiological Consequences: Destruction of alveolar walls results in the loss of pulmonary elastic recoil. During expiration, terminal bronchioles collapse prematurely, trapping air within the lungs (hyperinflation). Vital capacity drops, residual volume increases dramatically, and the total surface area available for gas exchange is severely reduced.
• Clinical Appearance: Thin, frail, asthenic habitus; dyspneic with pursed-lip expiration (which creates positive end-expiratory pressure to splint collapsing bronchioles open); tachypneic; barrel chest deformity; reddish-pink complexion because they maintain relatively normal blood gas tensions through intense respiratory exertion.

Biomechanics of Respiration & Accessory Muscle Hypertonicity

In COPD, pulmonary hyperinflation flattens the dome of the diaphragm, shortening its muscle fibers and aligning them horizontally. The diaphragm loses its mechanical mechanical advantage and can no longer generate negative intrathoracic pressure. To sustain ventilation, the patient is forced to rely continuously on accessory muscles of inspiration:

• Primary Accessory Muscles: Scalenes (anterior, middle, posterior), sternocleidomastoid (SCM), and pectoralis minor pull the upper ribs upward.
• Secondary Accessory Muscles: Upper trapezius, levator scapulae, subclavius, serratus anterior, and latissimus dorsi.
• Postural Consequences: Accessory muscles develop severe chronic hypertonicity, active myofascial trigger points, and adaptive shortening, pulling the head into forward head posture and the shoulders into protraction and elevation. Over time, the thoracic cage becomes rigid, developing a fixed barrel chest (increased anteroposterior diameter, elevated sternum, horizontal ribs).

RMT Treatment Planning & Clinical Modifications for COPD

• Therapeutic Positioning:
  • Orthopnea: Patients with COPD cannot tolerate lying flat supine (which forces abdominal viscera against the flattened diaphragm, causing acute respiratory distress).
  • Recommended Postures: Position in a semi-Fowler position (head and torso elevated 30° to 45°), side-lying with supportive pillows, or seated forward-leaning with the forearms supported on pillows on a treatment table (the "tripod position," which fixes the shoulder girdle and allows pectoralis minor to assist rib elevation).
• Manual Techniques: Gentle, soothing myofascial release, broad contact petrissage, and gentle trigger point deactivation directed to the scalenes, SCM, intercostals, and pectoralis minor. Avoid aggressive, deep stripping that could provoke pain-induced hyperventilation or anxiety.
• Postural Drainage & Percussion (Tapotement):
  • Gentle cupped-hand tapotement (hollow-handed rhythmic percussion, not suction cupping) over posterior thoracic segments can assist in loosening retained mucus in chronic bronchitis.
  • Strict Precautions & Contraindications: Tapotement is strictly contraindicated if the patient has coexisting osteoporosis (common due to chronic corticosteroid therapy), rib fractures, active hemoptysis, unstable angina, or severe pulmonary hypertension.

---

2. Asthma & Reactive Airway Pathology

Asthma is a chronic inflammatory airway disorder characterized by bronchial hyperresponsiveness, reversible bronchospasm, mucosal edema, and tenacious mucus plug formation. The pathophysiology is driven by type 2 helper T-cell (Th2) immune responses, mast cell degranulation, and excessive eosinophilic infiltration releasing histamine, leukotrienes (C4, D4, E4), and platelet-activating factor.

Etiological Triggers

• Extrinsic (Atopic / Allergic) Asthma: Driven by IgE-mediated type I hypersensitivity reactions to inhaled environmental allergens (pollen, animal dander, dust mites, molds, chemical scents).
• Intrinsic (Non-Allergic) Asthma: Triggered by non-immune mechanisms, including respiratory viral infections, cold air inhalation, physical exercise (exercise-induced bronchoconstriction), emotional stress, or pharmacological agents (aspirin-exacerbated respiratory disease [AERD], beta-blockers).

Strict RMT Clinical Safety Protocols for Asthma

1. Scent-Free Clinical Environment: Essential oils, scented lotions, chemical cleaning agents, and scented diffusers can act as potent chemical triggers that provoke sudden, life-threatening bronchospasm. RMTs must utilize strictly hypoallergenic, fragrance-free massage lubricants.
2. Emergency Bronchodilator Verification: Prior to commencing any manual therapy, the RMT must confirm that the patient has their fast-acting rescue inhaler (short-acting beta-2 agonist, such as salbutamol / Ventolin) in the room, positioned within arm's reach on the bedside table or shelf. If the patient does not have their rescue inhaler on site, vigorous treatment must be postponed.
3. Management of an Acute Asthmatic Attack:
   • Cease massage immediately.
   • Assist the patient into a high seated or forward-leaning tripod position.
   • Facilitate the self-administration of 2 to 4 puffs of their rescue bronchodilator via spacer if available.
   • Encourage slow, pursed-lip diaphragmatic breathing to minimize air trapping.
   • Emergency Activation (911): If the patient shows no improvement within 5 minutes, displays cyanosis (blue lips/fingers), exhibits intercostal retractions, or is unable to speak in full sentences, immediately activate emergency medical services.

---

3. Autoimmune & Systemic Inflammatory Disorders

Autoimmune disorders involve a loss of immunological self-tolerance, leading to the production of autoantibodies, immune complex deposition, and chronic systemic microvascular and connective tissue damage. These conditions follow a cyclical course of acute exacerbations (flares) and remissions.

Rheumatoid Arthritis (RA)

Rheumatoid Arthritis is a chronic, systemic autoimmune inflammatory disorder characterized by persistent, symmetrical polyarthritis targeting synovial membranes of diarthrodial joints.

• Pathophysiology: Autoantibodies (Rheumatoid Factor [RF] and anti-cyclic citrullinated peptide [anti-CCP]) form immune complexes in the synovium. Macrophages and T-cells infiltrate the joint lining, causing profound synovial proliferation and angiogenesis. This invasive, hyperplastic, vascular granulation tissue is called a pannus. The pannus secretes matrix metalloproteinases, collagenases, and osteoclast-activating factors that systematically erode articular cartilage, destroy subchondral bone, and stretch joint capsules and collateral ligaments.
• Joint Distribution: Bilateral and symmetric; primarily affects the small joints of the hands and feet (metacarpophalangeal [MCP], proximal interphalangeal [PIP], and metatarsophalangeal [MTP] joints). Distal interphalangeal (DIP) joints are characteristically spared (a key distinction from osteoarthritis!).
• Clinical Presentation: Morning stiffness lasting greater than 1 hour (often 2–3 hours) that gradually improves with gentle movement; warm, boggy, spongy, swollen joints; fatigue, low-grade fever, and subcutaneous rheumatoid nodules over extensor surfaces.
• Classic Hand & Digit Deformities:
  • Swan-Neck Deformity: Hyperextension of the PIP joint with flexion of the DIP joint.
  • Boutonnière Deformity: Flexion of the PIP joint with hyperextension of the DIP joint.
  • Ulnar Drift: Ulnar (medial) deviation of the digits at the MCP joints, associated with extensor tendon subluxation.
• Critical Red Flag — Atlantoaxial Subluxation:
  • Synovial inflammation frequently targets the synovial joints between the atlas and axis (C1–C2), specifically destroying the transverse ligament of the atlas and alar ligaments.
  • This creates gross atlantoaxial instability; flexion of the cervical spine can cause the odontoid process (dens) to compress the cervical spinal cord and vertebral arteries.
  • Absolute Contraindication: High-velocity cervical manipulation, aggressive manual cervical traction, and forceful passive cervical flexion or rotation are strictly contraindicated in all RA patients.

Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus is a prototypical systemic autoimmune disorder characterized by multisystem autoantibody production (anti-nuclear antibodies [ANA], anti-double-stranded DNA [anti-dsDNA], anti-Smith antibodies) and widespread immune complex deposition in microvasculature.

• Clinical Presentation:
  • Cutaneous: Classic malar (butterfly) rash across the bridge of the nose and malar eminences sparing the nasolabial folds; discoid lupus plaques; marked photosensitivity.
  • Musculoskeletal: Non-erosive, migratory, symmetrical polyarthralgia and arthritis without the severe bony destruction seen in RA; Jaccoud's arthropathy (reversible digit deformities).
  • Systemic Involvement: Lupus nephritis (renal failure risk), pericarditis, pleuritis, Raynaud's phenomenon, and neuropsychiatric complications.
• RMT Modifications: Monitor for systemic flares, avoid direct pressure over cutaneous facial rashes, modify techniques for vascular fragility, and position in semi-Fowler if pleuritic pain is present.

Ankylosing Spondylitis (AS)

Ankylosing Spondylitis is a chronic, progressive, seronegative (RF-negative) inflammatory spondyloarthropathy with a strong genetic association with the HLA-B27 human leukocyte antigen (present in >90% of patients).

• Primary Pathophysiological Site — Enthesitis: The primary inflammatory lesion in AS is enthesitis—inflammation at the anatomical insertion sites of tendons, ligaments, and joint capsules into bone (entheses), rather than the synovium. Common sites include the Achilles tendon insertion, plantar fascia origin, and costosternal junctions.
• Progression of Spinal Ankylosis:
  1. Bilateral, symmetrical sacroiliitis (inflammation of the sacroiliac joints) is the universal starting point.
  2. Ascending inflammation involves the vertebral bodies and intervertebral discs. Chondroid metaplasia and ossification of the outer fibers of the annulus fibrosus produce vertical bony bridges called syndesmophytes.
  3. Syndesmophytes fuse adjacent vertebral bodies, obliterating spinal motion and producing the classic radiographic "bamboo spine".
• Clinical Presentation: Predominantly young males (onset typically between 15 and 30 years). Insidious onset of dull, persistent lower back and gluteal ache accompanied by morning stiffness lasting >1 hour that improves with physical exercise and movement, but does NOT improve with rest (in contrast to mechanical low back pain).
• Structural Changes: Complete loss of lumbar lordosis, thoracic hyperkyphosis, forward head carriage, and compensatory hip flexion.
• Costovertebral Ankylosis & Chest Expansion Testing:
  • Ossification of costovertebral and costotransverse joints fuses the ribs to the spine, severely restricting chest expansion during breathing.
  • Chest Expansion Assessment: Measured with a tape measure around the thorax at the level of the 4th intercostal space. The difference between maximal expiration and maximal inspiration is measured. A measurement of less than 2.5 cm of thoracic expansion is abnormal and indicative of advanced costovertebral ankylosis.
  • Patients become entirely dependent on diaphragmatic breathing for ventilation.

---

4. Autoimmune Flare-Up vs. Remission Management Matrix